P3 Health Partners Inc. (PIII)
NASDAQ (CM) NASDAQ (CM) Primary 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Pa
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Par
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Pa
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partn
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
P3 Health Partners (PIII) Shows Fast-paced Momentum But Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, P3 Health Partners (PIII) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
P3 Health Partners Inc. (PIII) Q2 2024 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2024 Earnings Call August 7, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical Officer Bill Bettermann - Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Ryan Langston - TD Cowen Jack Senft - William Blair Operator Good day, and welcome to the P3 Health Partners Second Quarter 2024 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Tops Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.09 per share a year ago.
Will P3 Health Partners Inc. (PIII) Report Negative Earnings Next Week? What You Should Know
P3 Health Partners (PIII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is P3 Health Partners (PIII) Stock Down 4% Today?
P3 Health Partners (NASDAQ: PIII ) stock is falling on Tuesday after the company sold shares and warrants to institutional investors in a recent offering. P3 Health Partners reveals in a filing with the Securities and Exchange Commission (SEC) that it issued roughly 67.4 million shares of PIII stock to institutional investors.
